Trinean appoints Chris van Ingen as member of the board

Gentbrugge, Belgium: 2 May 2014 - Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced that it appointed Mr. Chris van Ingen as independent board member.

"We are very pleased to be working with Chris van Ingen," comments Philippe Stas, CEO of Trinean. "His broad experience in the life science instrumentation field will be valuable to bring Trinean in its next phase of expansion."

More info on the press release or on Trinean's website.  

Next > FRX Polymers Inc. completes US$ 20M Series C financing

Previous > iSTAR Medical Adds Glaucoma Pioneer Prof. Michael Belkin, MD, to Scientific Advisory Board